- Associated Press - Wednesday, January 21, 2015

DALLAS (AP) - One of two Dallas nurses who contracted Ebola last year is donating blood to a biotech firm to determine if her antibodies can be used to develop a drug to combat the deadly disease.

Amber Vinson gave the blood Wednesday to drug development company XBiotech.

XBiotech CEO John Simard told WFAA-TV in Dallas (https://bit.ly/1umsmBu ) that those who survive Ebola have “very good antibodies” that could be the foundation for developing a resistance to the disease.

Vinson’s donation isn’t the first; Dr. Kent Brantly and others who have contracted Ebola have given blood plasma to help treat victims.

Vinson became infected while treating a Liberian who fell ill during a visit to Dallas last fall. Both she and the second nurse have recovered.

Brantly contracted the disease treating patients in Liberia.


Information from: WFAA-TV, https://www.wfaa.com

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide